Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 9Genitourinary 8Head & Neck 7Thoracic 4Lymphoid 4Other hematologic neoplasm 3Gynecologic 3Breast 3Plasma cell 2Dermatologic 2CNS 2Other solid neoplasm 1Other neoplasm 1Other 1Endocrine 1

Conditions

Osteoporosis 1Obesity 1Hypertension 1Hypercholesterolemia 1Diabetes Mellitus 1Cushing Syndrome 1Adrenal incidentaloma 1Adrenal Gland Neoplasms 1

Interventions

Everolimus 27pembrolizumab 25Temozolomide 24lutetium Lu 177 dotatate 22Nivolumab 18Magnetic Resonance Spectroscopy 18lenvatinib 17cabozantinib 17Cisplatin 16Sunitinib 15Capecitabine 14Bevacizumab 14Specimen Handling 12Sorafenib 12trametinib 10Ipilimumab 10Etoposide 10pasireotide 9dabrafenib 9Paclitaxel 9Carboplatin 8pazopanib 7lanreotide 7Octreotide 7Fluorodeoxyglucose F18 7anlotinib 6Irinotecan 6Injections 6Doxorubicin 6surufatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Observation × Endocrine × Clear all
NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
4 enrolled 10 charts
EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡